Docetaxel: an alternative taxane in ovarian cancer

Por Katsumata, N
Publicado em 2003

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a...

Por Katsumata, N
Publicado em 2013

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer

Por Katsumata, N., Hirai, Y., Kamiura, S., Sugiyama, T., Kokawa, K., Hatae, M., Nishimura, R., Ochiai, K.
Publicado em 2011

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised,...

Por Saito, H., Yoshizawa, H., Yoshimori, K., Katakami, N., Katsumata, N., Kawahara, M., Eguchi, K.
Publicado em 2013

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus

Por Kasamatsu, T, Onda, T, Katsumata, N, Sawada, M, Yamada, T, Tsunematsu, R, Ohmi, K, Sasajima, Y, Matsuno, Y
Publicado em 2003

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Por Hirata, T, Shimizu, C, Yonemori, K, Hirakawa, A, Kouno, T, Tamura, K, Ando, M, Katsumata, N, Fujiwara, Y
Publicado em 2009

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

Por Tokuda, Y, Watanabe, T, Omuro, Y, Ando, M, Katsumata, N, Okumura, A, Ohta, M, Fujii, H, Sasaki, Y, Niwa, T
Publicado em 1999

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

Por Tanioka, M, Shimizu, C, Yonemori, K, Yoshimura, K, Tamura, K, Kouno, T, Ando, M, Katsumata, N, Tsuda, H, Kinoshita, T, Fujiwara, Y
Publicado em 2010

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Por Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Publicado em 2014

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Onco...

Por Katsumata, N, Yoshikawa, H, Kobayashi, H, Saito, T, Kuzuya, K, Nakanishi, T, Yasugi, T, Yaegashi, N, Yokota, H, Kodama, S, Mizunoe, T, Hiura, M, Kasamatsu, T, Shibata, T, Kamura, T
Publicado em 2013

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

Por Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Publicado em 2009

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

Por Ando, M., Watanabe, T., Sasaki, Y., Ying, D. F., Omuro, Y., Katsumata, N., Narabayashi, M., Tokue, Y., Fujii, H., Igarashi, T., Wakita, H., Ohtsu, T., Itoh, K., Adachi, I., Taguchi, T.
Publicado em 1998

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

Por Katsumata, N, Noda, K, Nozawa, S, Kitagawa, R, Nishimura, R, Yamaguchi, S, Aoki, D, Susumu, N, Kuramoto, H, Jobo, T, Ueki, K, Ueki, M, Kohno, I, Fujiwara, K, Sohda, Y, Eguchi, F
Publicado em 2005